Procter & Gamble Health quarterly results and financials

Procter & Gamble Health (PGHL)₹5,700−0.30%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Procter & Gamble Health reported sales of ₹363 Cr, up 7.4% from Jun 2025, and net profit of ₹95.80 Cr, up 45.3% year on year. For the year to Mar 2026, sales were ₹1,404 Cr and net profit ₹326 Cr.

Sales (Jun 2026): ₹363 Cr
Net profit (Jun 2026): ₹95.80 Cr
Sales (FY Mar 2026): ₹1,404 Cr
Net profit (FY Mar 2026): ₹326 Cr
EPS (Jun 2026): ₹57.78
Borrowings (Mar 2026): ₹9.02 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Procter & Gamble Health quarterly results

₹ crore unless stated; each column is a quarter.

Procter & Gamble Health Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	304	309	251	283	312	309	310	338	324	373	369	363
Expenses	216	208	185	236	199	186	230	248	205	263	235	263
Operating Profit	89.35	102	67.21	48.15	114	123	81.26	90.27	120	110	136	100
OPM %	28.9%	33.0%	27.0%	17.0%	36.0%	40.0%	25.9%	27.0%	37.0%	29.9%	36.9%	27.0%
Other Income	5.98	4.99	1.99	−17.96	2.99	3.99	2.99	3.99	4.99	3.99	3.99	35.94
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	5.98	6.98	6.97	6.97	5.98	5.98	4.98	4.98	5.98	5.97	5.97	5.98
Profit before tax	87.63	99.67	62.81	22.92	111	122	78.76	88.62	119	109	133	129
Tax %	26.0%	28.0%	26.1%	26.1%	26.1%	25.1%	22.1%	25.1%	26.1%	29.1%	29.0%	26.1%
Exceptional items	0.00	0.00	0.00	−9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	24.10
Net Profit	65.83	71.88	46.88	16.97	81.89	90.88	60.87	65.91	88.78	77.79	94.82	95.80
EPS (Rs)	39.43	43.36	28.01	10.10	49.52	54.64	36.82	39.83	53.26	46.67	56.93	57.78

Procter & Gamble Health profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Procter & Gamble Health Profit and loss
	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Jun 2020 18m	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025 9m	Mar 2026	TTM
Sales	989	695	845	924	1,350	1,006	1,110	1,226	1,148	930	1,404	1,428
Expenses	876	621	700	721	1,035	761	845	904	844	615	949	966
Operating Profit	116	77.22	148	205	320	247	269	326	308	320	458	468
OPM %	12.0%	11.0%	16.9%	22.0%	24.0%	24.0%	24.0%	26.0%	27.0%	33.9%	31.9%	32.7%
Other Income	23.93	73.83	766	47.91	65.88	17.97	12.97	17.95	−4.99	9.97	16.95	48.91
Interest	0.00	0.00	0.00	0.00	0.00	0.99	0.00	0.99	0.99	0.00	0.99	0.00
Depreciation	24.89	18.92	20.91	16.93	28.87	29.90	26.91	27.89	26.88	16.94	23.90	23.90
Profit before tax	115	131	892	233	354	232	252	313	272	311	449	488
Tax %	31.1%	29.1%	6.0%	32.1%	28.1%	24.1%	24.1%	27.1%	26.1%	25.1%	27.0%	—
Exceptional items	0.00	12.04	6.02	0.00	−2.01	0.00	0.00	1.01	−15.05	0.00	0.00	24.10
Net Profit	78.78	93.73	837	159	254	177	193	228	201	233	326	357
EPS (Rs)	47.59	56.46	504.71	95.44	152.85	106.26	115.70	138.05	120.92	141.01	196.72	214.64
Dividend payout %	23.0%	27.0%	87.0%	0.0%	150.0%	122.0%	45.0%	69.0%	215.0%	89.0%	211.0%	—

Procter & Gamble Health balance sheet

₹ crore, at each year end.

Procter & Gamble Health Balance sheet
	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	Mar 2026
Equity Capital	16.99	17.01	17.01	17.01	16.99	17.01	17.02	17.01	17.01	17.02	17.02	16.99
Reserves	576	648	718	1,526	802	892	688	601	735	523	521	509
Borrowings	0.00	0.00	0.00	0.00	0.00	0.00	8.01	3.01	12.03	10.02	8.02	9.02
Other Liabilities	192	215	258	220	250	269	276	269	339	247	250	309
Total Liabilities	785	880	992	1,762	1,068	1,179	988	889	1,103	795	796	843
Fixed Assets	132	111	115	104	101	101	104	112	144	128	116	102
CWIP	7.02	30.11	9.03	17.05	11.04	21.09	39.12	41.16	32.13	6.02	11.04	14.04
Investments	41.99	27.98	69.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	604	712	798	1,642	955	1,055	845	737	926	661	668	728
Inventories	167	164	158	113	114	134	118	115	135	109	109	137
Trade receivables	127	107	123	66.02	77.02	94.94	59.95	83.01	116	84.90	145	164
Cash & equivalents	188	280	278	1,245	569	640	469	326	441	244	189	185
Total Assets	785	880	992	1,762	1,068	1,179	988	889	1,103	795	796	843

Procter & Gamble Health cash flow

₹ crore, for each year.

Procter & Gamble Health Cash flow
	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	Mar 2026
Cash from operating activity	83.12	107	54.02	−130	235	247	170	236	228	169	339
Cash from investing activity	−67.99	−74.96	−48.02	1,269	165	−32.01	−25.99	−22.01	−6.99	9.99	1.01
Cash from financing activity	−12.02	−15.02	−22.03	−30.02	−884	−388	−290	−98.12	−419	−235	−344
Net cash flow	3.99	16.99	−16.01	1,108	−483	−172	−145	116	−197	−55.95	−4.99
Capex	45.05	31.55	30.17	26.61	23.19	52.42	37.78	42.35	21.66	8.53	15.46
Free cash flow	37.90	74.87	23.96	−157	211	196	132	198	207	168	322
CFO / OP %	136.0%	138.0%	147.0%	117.0%	106.0%	128.0%	87.0%	100.0%	102.0%	78.0%	97.0%

Procter & Gamble Health ratios

Working-capital days and returns, by year.

Procter & Gamble Health Ratios
	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	Mar 2026
Debtor days	49	39	64	28	30	26	22	27	34	27	57	43
Inventory days	140	145	243	154	139	113	138	124	136	120	152	137
Days payable	55	67	128	124	106	105	209	185	239	184	239	192
Cash conversion cycle	135	119	180	59	64	35	−48	−33	−68	−36	−29	−12
Working capital days	69	52	94	42	22	23	7	17	15	19	48	30
ROCE %	14.9%	17.9%	15.9%	77.9%	19.9%	28.9%	28.9%	37.9%	44.9%	44.9%	47.9%	83.9%

Procter & Gamble Health: frequently asked questions

What are the latest quarterly results of Procter & Gamble Health?

For the Jun 2026 quarter, Procter & Gamble Health reported sales of ₹363 Cr, up 7.4% year on year and net profit of ₹95.80 Cr, up 45.3% year on year. The operating margin was 27.0%.

What is the annual revenue of Procter & Gamble Health?

Procter & Gamble Health's sales for the year to Mar 2026 were ₹1,404 Cr; over the last twelve months they were ₹1,428 Cr.

What is the net profit of Procter & Gamble Health?

Net profit for the year to Mar 2026 was ₹326 Cr, and ₹357 Cr over the last twelve months. Earnings per share over the same trailing period were ₹214.64.

How much debt does Procter & Gamble Health have?

Procter & Gamble Health reported borrowings of ₹9.02 Cr at Mar 2026, against cash and equivalents of ₹185 Cr.

What is the free cash flow of Procter & Gamble Health?

Cash from operations was ₹339 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹322 Cr.

Loading…